Edition:
United Kingdom

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

11.93CNY
23 Oct 2018
Change (% chg)

¥-0.06 (-0.50%)
Prev Close
¥11.99
Open
¥11.99
Day's High
¥12.40
Day's Low
¥11.81
Volume
11,222,909
Avg. Vol
8,649,277
52-wk High
¥17.75
52-wk Low
¥10.38

Latest Key Developments (Source: Significant Developments)

Zhejiang Hisun Pharmaceutical receives approval for drug clinical trial
Monday, 21 May 2018 

May 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for drug clinical trial for a kind of injection, from China Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical and unit obtain high-tech enterprise recognition and to enjoy tax preference
Thursday, 4 Jan 2018 

Jan 4(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it and unit were recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Zhejiang Hisun Pharmaceutical passes FDA approval
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for a kind of tablet from U.S Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical unit says product gets FDA approval
Monday, 20 Nov 2017 

Nov 20(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says co's Hangzhou-based unit's product simvastatin tablets, gets approval from U.S. Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical says product gets FDA approval
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says its product, mycophenolate mofetil capsules, gets approval from U.S. Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical says change of CFO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says it appoints Liu Yuanyan as new CFO, replacing Guan Xuhua who resigns from the position due to internal change in job role.  Full Article

Zhejiang Hisun Pharmaceutical receives TGA-GMP certificate
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received goods manufacture practice (GMP) certificate from Therapeutic Goods Administration .Certificate issued to crude drugs manufactured by the company and the valid period is until Nov. 26, 2020 .  Full Article

Zhejiang Hisun Pharmaceutical to invest 5.1 mln yuan to set up investment management JV
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:* Says it will invest 5.1 million yuan to set up Zhejiang-based investment management JV, which will be engaged in operation of pharmaceutical industry innovation projects, and hold 51 percent stake in JV after transaction .  Full Article

China blue-chips gain on trade talk plan; Shanghai lower

SHANGHAI, Sept 14 China's blue-chip index closed higher on Friday, following its peers in the region, on prospects of a new round of trade talks between China and the U.S., but mixed economic data weighed on the Shanghai Composite index.